Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older

Clinical trial NCT05426174 · COMPLETED

Trial details

NCT number: NCT05426174
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza Immunization Healthy Volunteers

Start date: 2022-06-09
Primary completion: 2024-01-03
Enrollment: 233

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.